Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice

Cited 13 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorJ Y Shin-
dc.contributor.authorY S Chung-
dc.contributor.authorB Kang-
dc.contributor.authorH L Jiang-
dc.contributor.authorDae Yeul Yu-
dc.contributor.authorK Han-
dc.contributor.authorC Chae-
dc.contributor.authorJ H Moon-
dc.contributor.authorG Jang-
dc.contributor.authorM H Cho-
dc.date.accessioned2017-04-19T09:38:54Z-
dc.date.available2017-04-19T09:38:54Z-
dc.date.issued2013-
dc.identifier.issn0929-1903-
dc.identifier.uri10.1038/cgt.2013.6ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/11278-
dc.description.abstractAs hepatocellular carcinoma (HCC) is one of the most common tumors worldwide, development of novel therapeutic approaches for HCC is urgently needed. Two different genes, LETM1 and CTMP, which target mitochondrial functions, were chosen and linked using 2A-peptide sequence. Successful self-cleavage of 2A-peptide induced synergistic antitumor effect in the liver of H-ras12V, the HCC model mice, by simultaneous activation of LETM1 (Leucine zipperEF hand-containing transmembrane-1) and CTMP (carboxyl-terminal modulator protein). Overexpression of LETM1 and CTMP significantly reduced the incidence of tumorigenesis, which were confirmed by gross and microscopic observations. Morphological changes in mitochondria, such as swelling and loss of cristae, were significant, and the prolonged activation of defects in mitochondrial function led to mitochondria-mediated apoptosis. Furthermore, with CTMP as a direct binding partner of Akt1, and LETM1 as a binding partner of CTMP, LETM1-2A-CTMP downregulated the Akt1 pathway at both Ser473 and Thr308 sites of phosphorylation. Proliferation and angiogenesis, which are important in cancer prognosis, were reduced in tumor sites after introduction of LETM1-2A-CTMP. Taken together, the results indicate that introduction of the mitochondria-targeting genes, LETM1 and CTMP, and self-processing capacity of 2A-peptide sequence exerts an antitumor effect in liver of H-ras12V mice, suggesting its potential as a tool for gene therapy.-
dc.publisherSpringer-Nature Pub Group-
dc.titleCo-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice-
dc.title.alternativeCo-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice-
dc.typeArticle-
dc.citation.titleCancer Gene Therapy-
dc.citation.number3-
dc.citation.endPage194-
dc.citation.startPage186-
dc.citation.volume20-
dc.contributor.affiliatedAuthorDae Yeul Yu-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeNameJiang-
dc.contributor.alternativeName유대열-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.contributor.alternativeName-
dc.identifier.bibliographicCitationCancer Gene Therapy, vol. 20, no. 3, pp. 186-194-
dc.identifier.doi10.1038/cgt.2013.6-
dc.subject.keyword2A-peptide-
dc.subject.keywordCTMP-
dc.subject.keywordGPCS-
dc.subject.keywordLETM1-
dc.subject.keywordliver cancer-
dc.subject.local2A-peptide-
dc.subject.localCTMP-
dc.subject.localGPCS-
dc.subject.localGPC-
dc.subject.localLETM1-
dc.subject.localLiver cancer-
dc.subject.localliver cancer-
dc.subject.localLiver Cancer-
dc.description.journalClassY-
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.